Home » Topics » Regulatory

Regulatory
RSS

Valtrex approved for treatment of cold sores

Sep. 16, 2002

New E.U. approvals sought for Pennsaid

Sep. 16, 2002

Milnacipran phase II trial in FMS completes enrollment ahead of schedule

Sep. 13, 2002

J&J to file for two new indications for Topamax

Sep. 12, 2002

Pediatric indication approved for Zenapax

Sep. 4, 2002

Lexapro approved for treatment and maintenance treatment of major depressive disorder

Sep. 2, 2002

E.U. approval for Visudyne

Sep. 2, 2002

Neulasta approved in E.U.

Aug. 30, 2002

E.U. approval for Aranesp

Aug. 29, 2002

Ortho Tri-Cyclen Lo receives FDA approval

Aug. 26, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...